Position in ALNY
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,618,036
-$2,095,318 QoQ
Shares Held
5,375
-52.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#351
of 784 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ASR Vermogensbeheer N.V. holds $37,601,819 across 6 Biotechnology names. ALNY ranks #5 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
25,471 | $12,652,209 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
15,098 | $9,414,206 | |
| 3 | RPRX |
Royalty Pharma plc
|
122,222 | $6,852,987 | |
| 4 | INCY |
Incyte Corp
|
57,499 | $6,518,086 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
5,375 | $1,618,036 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,917 | $546,295 |
All Filings in ALNY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,618,036 | 5,375 | Shares | Defined | 2026-07-20 | |
| 2026-03-31 | $3,713,354 | 11,223 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $4,382,898 | 11,022 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $4,047,456 | 8,876 | Shares | Defined | 2025-10-28 | |
| 2025-06-30 | $2,910,679 | 8,926 | Shares | Defined | 2025-07-21 | |
| 2025-03-31 | $2,366,185 | 8,763 | Shares | Defined | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||